SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Neuland Laboratories informs about outcome of Board Meeting

30 Oct 2014 Evaluate

Neuland Laboratories has informed that the Board of Directors of the Company at its meeting held on October 29, 2014, allotted 12,22,472 fully-paid up Equity Shares of Face Value of Rs. 10 each, out of the Rights Issue of 12,25,276 Equity shares and the balance has been kept in abeyance.

The above information is a part of company’s filings submitted to BSE

Neuland Laboratories Share Price

14408.95 -539.25 (-3.61%)
24-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1619.95
Dr. Reddys Lab 1315.85
Cipla 1294.75
Zydus Lifesciences 927.15
Lupin 2296.10
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×